In the early and advanced stages of NAFLD, platelet recruitment to the liver is mediated by KCs through hyaluronan-CD44 binding, and platelet activation by Glycoprotein GPIbα, contributing to NASH and HCC development [53]. Here, TBCE is linked to metabolic dysfunction-associated steatotic liver disease.